期刊
CANCER BIOLOGY & THERAPY
卷 7, 期 8, 页码 1297-1301出版社
LANDES BIOSCIENCE
DOI: 10.4161/cbt.7.8.6301
关键词
c-jun; cancer; apoptosis; deoxyribozyme; liposarcoma; orthotopic; gene therapy
类别
资金
- Australian Orthopaedics Association
- Victorian Orthopaedics Research Trust Grant
c-jun has been found to be upregulated in a variety of cancers. Recently, this oncogene has also been implicated in liposarcoma (LS) progression. c-jun knockdown mediated by a deoxyribozyme induced apoptosis in LS cells via evoking caspase-10, but not the Fas/FasL pathway. A novel orthotopic model for LS was established in the hindlimb of mice using human cells to extend the evaluation of effects of c-jun knockdown in vivo. Tumor take in vivo was 100%, with growths resembling high grade aggressive LS. The c-jun deoxyribozyme inhibited the growth of LS in this model. Clinically, downregulation of c-jun may proffer an improved treatment outcome for liposarcoma. The new model for LS described here will enable better testing of agents with therapeutic potential against LS.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据